Plasma Concentration Studies

CJC-1295 / Ipamorelin

Mod GRF 1-29 + Ipamorelin

Modified GRF + Ipamorelin

CJC/Ipa Blend

A strategic peptide combination engineered to enhance gh release through synchronized GHRH and ghrelin receptor activation in experimental research models. Premium Research Peptide.

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

99.84%
Purity
Variant
CJC1295 NO DAC/Ipamorelin 5mg/5mg
Lot #
Clear Blue Cap
Labeled
10mg blend
Actual
11.82mg total
Ipamorelin
6.60mg
CJC-1295
5.22mg
Tested
Apr 14, 2026

Compound Information

Technical specifications

CJC-1295 (No DAC)

GHRH Analog Component

Other names
Mod GRF 1-29, Modified GRF
Type
GHRH analog
Amino Acids
29
Molecular Weight
~3,367 g/mol
Mechanism
GHRH receptor agonist
Half-life (No DAC)
30 min - 2 hours
Ipamorelin

Selective GHRP Component

Type
Growth hormone secretagogue
Amino Acids
5 (pentapeptide)
Molecular Weight
711.85 g/mol
Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH2
Mechanism
Ghrelin receptor (GHSR-1a) agonist
Selectivity
No cortisol/prolactin elevation
Blend Information

Why This Combination

Typical ratio
1:1 by weight
Combined half-life
1-2 hours (functional)
Synergy factor
~2.7× vs single pathway
Route
Subcutaneous injection
All the research peptides you need, with the peace of mind and research community at your fingertips.

Research Verification

Pèptido Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.